Overview


FutureWise Market Research has released a report that provides an intricate analysis of Small Molecule Drug Discovery Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share, and regional proliferation of this business. Moreover, the report offers insights into the current stature of prominent market players in the competitive landscape analysis of this market.

According to a research study conducted by FutureWise research analysts, the Small Molecule Drug Discovery Market is expected to experience substantial growth by the end of the forecast period. The report predicts that this business is expected to register a notable growth rate over the forecast period. This report provides crucial information on the total valuation currently held by the industry, as well as a segmentation of the market and an overview of the growth opportunities present across this business vertical.

  • ICON plc
  • Charles River Laboratories
  • Promega Corporation
  • Eurofins Discovery
  • Schrödinger Inc.
  • Labcorp Drug Development
  • Thermo Fisher Scientific Inc.
  • Jubilant Biosys Ltd.
  • Syngene International Ltd.
  • Curia Global Inc.
  • Evotec SE
  • WuXi AppTec
  • GenScript Biotech
  • ChemPartner
  • Domainex Ltd.
  • BenevolentAI
  • Insilico Medicine
  • AstraZeneca
  • Pfizer Inc.
  • BioDuro-Sundia
  • HitGen Inc.
  • Atomwise Inc.

(Note: The list of major players will be updated with the latest market scenario and trends.)

By Therapeutic Area

  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Metabolic Disorders
  • Gastrointestinal
  • Infectious Diseases
  • Autoimmune Disorders
  • Other Therapeutic Areas

By Process/Phase

  • Target Identification & Validation
  • Hit Generation & Selection
  • Lead Identification
  • Lead Optimization
  • Pre-clinical Candidate Selection

By Drug Type

  • Synthetic Small Molecules
  • Natural-Product Derivatives
  • Peptide Mimetics
  • PROTACs & Molecular Glues
  • Nucleoside Analogues

By Technology

  • High-Throughput Screening (HTS)
  • Fragment-Based Drug Discovery (FBDD)
  • Structure-Based Drug Design (SBDD)
  • Computational / AI-Driven Design
  • DNA-Encoded Library Screening
  • CRISPR-Based Target Validation
  • Bioassay Development & Cell-based Platforms

By End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide an exhaustive analysis of the Small Molecule Drug Discovery Market By Therapeutic Area, By Process, By Drug Type, By Technology, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
  • To record and evaluate the competitive landscape, mapping- product launches, technological advancements, mergers, and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Small Molecule Drug Discovery Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing Focus of Small Molecule Drug Discovery Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Small Molecule Drug Discovery Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Small Molecule Drug Discovery Market, By Therapeutic Area Historical Analysis and Forecast 2025-2033 (USD Million)
      1. Oncology
      2. Central Nervous System
      3. Cardiovascular
      4. Respiratory
      5. Metabolic Disorders
      6. Gastrointestinal
      7. Infectious Diseases
      8. Autoimmune Disorders
      9. Other Therapeutic Areas
  • 8.  Small Molecule Drug Discovery Market, By Process Historical Analysis and Forecast 2025-2033 (USD Million)
      1. Target Identification & Validation
      2. Hit Generation & Selection
      3. Lead Identification
      4. Lead Optimization
      5. Pre-clinical Candidate Selection
  • 9.  Small Molecule Drug Discovery Market, By Drug Type Historical Analysis and Forecast 2025-2033 (USD Million)
      1. Synthetic Small Molecules
      2. Natural-Product Derivatives
      3. Peptide Mimetics
      4. PROTACs & Molecular Glues
      5. Nucleoside Analogues
  • 10.  Small Molecule Drug Discovery Market, By Technology Historical Analysis and Forecast 2025-2033 (USD Million)
      1. High-Throughput Screening (HTS)
      2. Fragment-Based Drug Discovery (FBDD)
      3. Structure-Based Drug Design (SBDD)
      4. Computational / AI-Driven Design
      5. DNA-Encoded Library Screening
      6. CRISPR-Based Target Validation
      7. Bioassay Development & Cell-based Platforms
  • 11.  Small Molecule Drug Discovery Market, By End User Historical Analysis and Forecast 2025-2033 (USD Million)
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Academic & Research Institutes
      4. Contract Research Organizations (CROs)
  • 12.  North America Small Molecule Drug Discovery Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 13.  Latin America Small Molecule Drug Discovery Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 14.  Europe Small Molecule Drug Discovery Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 15.  Asia Pacific Small Molecule Drug Discovery Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASIAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 16.  Middle East and Africa Small Molecule Drug Discovery Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 17.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 18.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Drug Types Offered and Financial Layouts)

    •    1. ICON plc
        1.1. Company Overview
        1.2. Drug Type Portfolio
        1.3. SWOT Analysis
        1.4. Financial Overview
        1.5. Strategic Overview
         2. Charles River Laboratories
        2.1. Company Overview
        2.2. Drug Type Portfolio
        2.3. SWOT Analysis
        2.4. Financial Overview
        2.5. Strategic Overview
         3. Promega Corporation
        3.1. Company Overview
        3.2. Drug Type Portfolio
        3.3. SWOT Analysis
        3.4. Financial Overview
        3.5. Strategic Overview
         4. Eurofins Discovery
        4.1. Company Overview
        4.2. Drug Type Portfolio
        4.3. SWOT Analysis
        4.4. Financial Overview
        4.5. Strategic Overview
         5. Schrödinger Inc.
        5.1. Company Overview
        5.2. Drug Type Portfolio
        5.3. SWOT Analysis
        5.4. Financial Overview
        5.5. Strategic Overview
         6. Labcorp Drug Development
        6.1. Company Overview
        6.2. Drug Type Portfolio
        6.3. SWOT Analysis
        6.4. Financial Overview
        6.5. Strategic Overview
         7. Thermo Fisher Scientific Inc.
        7.1. Company Overview
        7.2. Drug Type Portfolio
        7.3. SWOT Analysis
        7.4. Financial Overview
        7.5. Strategic Overview
         8. Jubilant Biosys Ltd.
        8.1. Company Overview
        8.2. Drug Type Portfolio
        8.3. SWOT Analysis
        8.4. Financial Overview
        8.5. Strategic Overview
         9. Syngene International Ltd.
        9.1. Company Overview
        9.2. Drug Type Portfolio
        9.3. SWOT Analysis
        9.4. Financial Overview
        9.5. Strategic Overview
        10. Curia Global Inc.
        10.1. Company Overview
        10.2. Drug Type Portfolio
        10.3. SWOT Analysis
        10.4. Financial Overview
        10.5. Strategic Overview
        11. Evotec SE
        11.1. Company Overview
        11.2. Drug Type Portfolio
        11.3. SWOT Analysis
        11.4. Financial Overview
        11.5. Strategic Overview
        12. WuXi AppTec
        12.1. Company Overview
        12.2. Drug Type Portfolio
        12.3. SWOT Analysis
        12.4. Financial Overview
        12.5. Strategic Overview
        13. GenScript Biotech
        13.1. Company Overview
        13.2. Drug Type Portfolio
        13.3. SWOT Analysis
        13.4. Financial Overview
        13.5. Strategic Overview
        14. ChemPartner
        14.1. Company Overview
        14.2. Drug Type Portfolio
        14.3. SWOT Analysis
        14.4. Financial Overview
        14.5. Strategic Overview
        15. Domainex Ltd.
        15.1. Company Overview
        15.2. Drug Type Portfolio
        15.3. SWOT Analysis
        15.4. Financial Overview
        15.5. Strategic Overview
        16. BenevolentAI
        16.1. Company Overview
        16.2. Drug Type Portfolio
        16.3. SWOT Analysis
        16.4. Financial Overview
        16.5. Strategic Overview
        17. Insilico Medicine
        17.1. Company Overview
        17.2. Drug Type Portfolio
        17.3. SWOT Analysis
        17.4. Financial Overview
        17.5. Strategic Overview
        18. AstraZeneca
        18.1. Company Overview
        18.2. Drug Type Portfolio
        18.3. SWOT Analysis
        18.4. Financial Overview
        18.5. Strategic Overview
        19. Pfizer Inc.
        19.1. Company Overview
        19.2. Drug Type Portfolio
        19.3. SWOT Analysis
        19.4. Financial Overview
        19.5. Strategic Overview
        20. BioDuro-Sundia
        20.1. Company Overview
        20.2. Drug Type Portfolio
        20.3. SWOT Analysis
        20.4. Financial Overview
        20.5. Strategic Overview
        21. HitGen Inc.
        21.1. Company Overview
        21.2. Drug Type Portfolio
        21.3. SWOT Analysis
        21.4. Financial Overview
        21.5. Strategic Overview
        22. Atomwise Inc.
        22.1. Company Overview
        22.2. Drug Type Portfolio
        22.3. SWOT Analysis
        22.4. Financial Overview
        22.5. Strategic Overview

  • 19.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.  FutureWise SME Key Takeaway Points for Client

    •    


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 113 519 7222
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11